Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Analogues vs DPP-4 Inhibitors in Newly Detected Type 1 Diabetes
NCT01235819Phase 4Completed
- Sponsor
- Command Hospital
- Start
- Nov 2010
- Primary completion
- Sep 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of exenatide and sitagliptin in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Command Hospital. Primary endpoint: Change in insulin requirement at 1 year. Started Nov 2010; status: completed.
02
Drugs
exenatidesitagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01235819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235819.